Clinical trial NCT04976179 - References

Iron Deficiency Anemia of Pregnancy — Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)

Citation(s)

•   Ajepe AA, Okunade KS, Sekumade AI, Daramola ES, Beke MO, Ijasan O, Olowoselu OF, Afolabi BB
  Prevalence and foetomaternal effects of iron deficiency anaemia among pregnant women in Lagos, Nigeria. PLoS One. 2020 Jan 23;15(1):e0227965. doi: 10.1371/journal.pone.0227965. eCollection 2020.
•   Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A
  Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol. 2005 Dec;106(6):1335-40. doi: 10.1097/01.AOG.0000185260.82466.b4.
•   Auerbach M, Gafter-Gvili A, Macdougall IC
  Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol. 2020 Apr;7(4):e342-e350. doi: 10.1016/S2352-3026(19)30264-9.
•   Auerbach M
  Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron. Reprod Health. 2018 Jun 22;15(Suppl 1):96. doi: 10.1186/s12978-018-0536-1.
•   Balarajan Y, Ramakrishnan U, Ozaltin E, Shankar AH, Subramanian SV
  Anaemia in low-income and middle-income countries. Lancet. 2011 Dec 17;378(9809):2123-35. doi: 10.1016/S0140-6736(10)62304-5. Epub 2011 Aug 1.
•   Bolarinwa OA
  Sample size estimation for health and social science researchers: The principles and considerations for different study designs. Niger Postgrad Med J. 2020 Apr-Jun;27(2):67-75. doi: 10.4103/npmj.npmj_19_20.
•   Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J; FER-ASAP investigators
  Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 2017 May 24;45(4):443-453. doi: 10.1515/jpm-2016-0050.
•   Bukar M, Audu B, Sadauki H, El-Nafaty AU, Mairiga A
  Prevalence of iron deficiency and megaloblastic anemia at booking in a secondary health facility in north eastern Nigeria. Nigerian Medical Journal. 2009;50(2):33-7.
•   Chandrasekaran N, De Souza LR, Urquia ML, Young B, Mcleod A, Windrim R, Berger H
  Is anemia an independent risk factor for postpartum depression in women who have a cesarean section? - A prospective observational study. BMC Pregnancy Childbirth. 2018 Oct 11;18(1):400. doi: 10.1186/s12884-018-2032-6.
•   Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J
  On the relative safety of parenteral iron formulations. Nephrol Dial Transplant. 2004 Jun;19(6):1571-5. doi: 10.1093/ndt/gfh185.
•   Common Terminology Criteria for Adverse Events (CTCAE); version 5
  0. Published: November 27, 2017. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES; National Institutes of Health; National Cancer Institute.
•   Consolidated Framework for Implementation Research (CFIR)
  Interview Guide Tool 2020 [Available from: https://cfirguide.org/guide/app/#/.
•   Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C
  Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
•   Dama M, Van Lieshout RJ, Mattina G, Steiner M
  Iron Deficiency and Risk of Maternal Depression in Pregnancy: An Observational Study. J Obstet Gynaecol Can. 2018 Jun;40(6):698-703. doi: 10.1016/j.jogc.2017.09.027. Epub 2018 Jan 4.
•   Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC
  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.
•   Demographic Statistics Bulletin
  Nigeria: National Bureau of Statistics; 2018.
•   Ehlken B, Nathell L, Gohlke A, Bocuk D, Toussi M, Wohlfeil S
  Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase between 2014 and 2017. Drug Saf. 2019 Mar;42(3):463-471. doi: 10.1007/s40264-018-0769-5.
•   Erhabor O, Isaac I, Isah A, Udomah F
  Iron Deficiency Anemia among Antenatal Women in Sokoto, Nigeria. British Journal of Medical and Health Sciences. 2013;1(4):47-57.
•   Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW; Nutrition Impact Model Study Group (anaemia)
  Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013 Jun 21;346:f3443. doi: 10.1136/bmj.f3443.
•   Kang SY, Kim HB, Sunwoo S
  Association between anemia and maternal depression: A systematic review and meta-analysis. J Psychiatr Res. 2020 Mar;122:88-96. doi: 10.1016/j.jpsychires.2020.01.001. Epub 2020 Jan 8.
•   Kochhar PK, Kaundal A, Ghosh P
  Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res. 2013 Feb;39(2):504-10. doi: 10.1111/j.1447-0756.2012.01982.x. Epub 2012 Aug 26.
•   Macrotrends
  Lagos, Nigeria Metro Area Population 1950-2020 2020 [Available from: https://www.macrotrends.net/cities/22007/lagos/population.
•   National Population Commission Nigeria
  National Demographic and Health Survey Nigeria 2018 [Available from: https://dhsprogram.com/pubs/pdf/FR359/FR359.pdf
•   Okafor I, Ibanga I, Asuquo J
  Prevalence of Anemia and Iron Deficiency Anemia among Pregnant Women in a Nigerian Rural Community. Sokoto Journal of Medical Laboratory Science. 2018;3(2):52-8.
•   Parks S, Hoffman MK, Goudar SS, Patel A, Saleem S, Ali SA, Goldenberg RL, Hibberd PL, Moore J, Wallace D, McClure EM, Derman RJ
  Maternal anaemia and maternal, fetal, and neonatal outcomes in a prospective cohort study in India and Pakistan. BJOG. 2019 May;126(6):737-743. doi: 10.1111/1471-0528.15585. Epub 2019 Jan 24.
•   Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T
  Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD004736. doi: 10.1002/14651858.CD004736.pub5.
•   Pollock RF, Muduma G
  A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000. Clinicoecon Outcomes Res. 2017 Aug 10;9:475-483. doi: 10.2147/CEOR.S139525. eCollection 2017.
•   Qassim A, Grivell RM, Henry A, Kidson-Gerber G, Shand A, Grzeskowiak LE
  Intravenous or oral iron for treating iron deficiency anaemia during pregnancy: systematic review and meta-analysis. Med J Aust. 2019 Oct;211(8):367-373. doi: 10.5694/mja2.50308. Epub 2019 Aug 22.
•   Radhika AG, Sharma AK, Perumal V, Sinha A, Sriganesh V, Kulshreshtha V, Kriplani A
  Parenteral Versus Oral Iron for Treatment of Iron Deficiency Anaemia During Pregnancy and post-partum: A Systematic Review. J Obstet Gynaecol India. 2019 Feb;69(1):13-24. doi: 10.1007/s13224-018-1191-8. Epub 2019 Jan 17.
•   Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD
  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health. 2015 Mar;18(2):161-72. doi: 10.1016/j.jval.2015.02.001.
•   Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, Pena-Rosas JP, Bhutta ZA, Ezzati M; Nutrition Impact Model Study Group (Anaemia)
  Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013 Jul;1(1):e16-25. doi: 10.1016/S2214-109X(13)70001-9. Epub 2013 Jun 25.
•   Vanderjagt DJ, Brock HS, Melah GS, El-Nafaty AU, Crossey MJ, Glew RH
  Nutritional factors associated with anaemia in pregnant women in northern Nigeria. J Health Popul Nutr. 2007 Mar;25(1):75-81.
•   Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H
  Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.
•   WHO
  The global prevalence of anemia in 2011. Geneva: World Health Organization. 2011 [Available from: https://apps.who.int/iris/bitstream/handle/10665/177094/9789241564960_eng.pdf,accessed?sequence=1.
•   WHO
  Treatments for iron-deficiency anemia in pregnancy. 2007 [Available from: https://extranet.who.int/rhl/topics/pregnancy-and-childbirth/medical-problems-during-pregnancy/anaemia-during-pregnancy/treatments-iron-deficiency-anaemia-pregnancy
•   WHO
  Trends in Maternal Mortality: 2000-2017 2019 [Available from: https://apps.who.int/iris/bitstream/handle/10665/327595/9789241516488-eng.pdf?ua=1
•   Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H
  Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA. 2020 Feb 4;323(5):432-443. doi: 10.1001/jama.2019.22450.

Intravenous Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Nigerian Women (IVON): an Open Label, Randomized Controlled Trial

Details for clinical trial NCT04976179